Tag: biosimilars

March 13, 2019

An Investor’s Overview to Biosimilars

Biosimilars are growing in popularity in both Canada and the US. Here is an overview of the biosimilars market for...
December 19, 2018

Biotech Outlook 2019: Will the Pressure Continue?

With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in...
October 14, 2018

10 Drugs Going Off Patent in 2018

A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
April 9, 2018

AveXis’ Share Price Soars with Acquisition Announcement

Global big pharma company Novartis started the week off on the right foot by announcing plans to acquire gene therapy...
February 8, 2018

Everthing You Need to Know About the Longevity Thematic ETF

In the last year, LNGR has given investors a 23.67 percent return, and is expected to increase by 29.38 percent...
January 9, 2018

Medical Device Outlook 2018: Taxes and Fees Could Damage Industry Growth

A new user fee and the lack of resolution on a returning tax has manufacturers worried about rising costs in...
March 14, 2017

OncBioMune Announces Term Sheet with EOC Pharma for Development of Telatinib

OncBioMune Pharmaceuticals (OTCQB:OBMP) announced an agreement with EOC Pharma, a U.S. subsidiary of the Chinese pharmaceutical Eddingpharm.